Caris Life Sciences, Inc. (CAI)
26.13
-0.14
(-0.53%)
USD |
NASDAQ |
Aug 24, 16:00
26.12
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences EPS Diluted (Quarterly) : -0.0022 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0022 |
| March 31, 2026 | -0.0018 |
| December 31, 2025 | 0.2901 |
| September 30, 2025 | 0.0862 |
| June 30, 2025 | -1.84 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.452 |
| December 31, 2024 | -0.2204 |
| September 30, 2024 | -0.3287 |
| June 30, 2024 | -0.3194 |
| March 31, 2024 | -0.4772 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CareDx, Inc. | 2.071 |
| Myriad Genetics, Inc. | -0.4557 |
| BioRestorative Therapies, Inc. | -0.1215 |
| Natera, Inc. | -0.4674 |
| Exagen, Inc. | -0.1323 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.637M |
| Revenue (Quarterly) | 263.71M |
| Total Expenses (Quarterly) | 264.35M |
| Enterprise Value | 7.043B |
| Gross Profit Margin (Quarterly) | 68.10% |
| Profit Margin (Quarterly) | -0.24% |
| Earnings Yield | 1.42% |
| Operating Earnings Yield | 2.08% |
| Normalized Earnings Yield | 1.702 |